DossierENTITY

islatravir

Coverage of islatravir in the Nexus archive.

Earliest in view: Jun 9 · 13:39 UTCMost recent: Jun 9 · 13:39 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 9 · 13:39 UTCSTAT NEWS
STAT+: Pharmalittle: We’re reading about a $10.6 billion GSK deal, an AstraZeneca obesity pill, and more
GSK acquired Nuvalent, a cancer drug developer, in a $10.6 billion deal to expand its oncology portfolio, while Merck and Gilead Sciences reported success in final-stage trials for a once-weekly HIV pill combining their experimental drugs. The GSK acquisition highlights ongoing biopharma industry consolidation as companies bolster pipelines amid generic competition.